SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Moshkevich Solomon
(Last) (First) (Middle)
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
(Street)
AUSTIN TX 78753
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/24/2024 		3. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President, ClinicalDiagnostics
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 167,051(1)(2) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) (3) 03/25/2025 Common Stock 5,752 $7.4491 D
Stock Option (right to buy) (3) 06/17/2025 Common Stock 3,323 $12.8501 D
Stock Option (right to buy) (3) 04/07/2026 Common Stock 27,501 $9.59 D
Stock Option (right to buy) (3) 06/08/2027 Common Stock 42,500 $10.41 D
Stock Option (right to buy) (3) 03/08/2028 Common Stock 20,000 $9.29 D
Stock Option (right to buy) (3) 03/07/2029 Common Stock 5,932 $15.57 D
Stock Option (right to buy) (3) 03/21/2029 Common Stock 34,000 $19.68 D
Explanation of Responses:
1. Includes (a) 82,816 shares of common stock held by the Reporting Person, (b) 1,375 shares subject to the Reporting Person's March 27, 2020 restricted stock unit ("RSU") grant that will vest in successive equal quarterly installments through March 27, 2024, (c) 2,004 shares subject to the Reporting Person's January 22, 2021 RSU grant that will vest in successive equal quarterly installments through January 21, 2025, (d) 4,566 shares subject to the Reporting Person's January 28, 2022 RSU grant that will vest in successive equal quarterly installments through January 20, 2026,
2. (continued from footnote 1) (e) 9,619 shares subject to the Reporting Person's June 10, 2022 RSU grant that will vest in successive equal annual installments through May 25, 2026, (f) 37,248 shares subject to the Reporting Person's January 27, 2023 RSU grant that will vest in successive equal quarterly installments through January 27, 2027, and (g) 29,423 shares subject to the Reporting Person's August 25, 2023 RSU grant that will vest full on September 1, 2026. The vesting of all such RSU grants is subject to the Reporting Person's continuous Service (as defined in the Issuer's Equity Incentive Plan, (the "2015 EIP")) through each such date and subject to acceleration as provided in the 2015 EIP.
3. The options are fully vested.
/s/ Tami Chen, Attorney-in-Fact 01/30/2024
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.